Brazilian Journal of Psychiatry · 2019 · 14 citations · 19 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPsychopharmacologySleep MedicineInsomnia DisordersInsomnia ManagementSleep AssessmentSleep Disorder PharmacotherapySleep ManagementSleep-wake DisordersNight AwakeningsNighttime AwakeningsPharmacologic Treatment Of InsomniaPharmacological Treatment Of InsomniaSleep Medication SafetySleep QualitySleep Quality AssessmentSleep Time
OBJECTIVE: To evaluate the safety and efficacy of a 5 mg sublingual dose of zolpidem, compared to a 10 mg oral dose, at bedtime and "as needed" following middle-of-the-night awakenings. METHODS: Participants were randomized into an oral group (oral zolpidem 10 mg and sublingual placebo at bedtime and "as-needed") and a sublingual group (oral placebo and sublingual zolpidem 5 mg at bedtime and "as-needed"). Participants underwent medical evaluation, polysomnography, the psychomotor vigilance test, and completed questionnaires. RESULTS: Of 85 patients, 67 met the criteria for insomnia (48±10 years; 79% women) and were randomized. Of these, 46 completed 92±5 days of treatment. Mild-to-moderate adverse events were reported by 25% of the participants, including headache, sleepiness, and dizziness. Both treatments decreased middle-of-the-night awakenings by an average of -3.1±2.3 days/week and increased total sleep time by 1.5 hours. Changes in sleep quality and insomnia severity scores were also favorable and comparable between groups: variation depended on continuation of treatment. Regarding PSG findings, sleep latency decreased more in the sublingual group than the oral group (-14±42 vs. 10±29 min; p = 0.03). The psychomotor vigilance test showed minor residual effects 30 minutes after awakening, which reversed after 2 hours. CONCLUSIONS: The safety and efficacy of both zolpidem formulations are comparable. The sublingual 5 mg dose induced sleep more rapidly. CLINICAL TRIAL REGISTRATION: NCT01896336.
19
The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research
Daniel J. Buysse, Charles F. Reynolds, T. H. Monk et al. · Psychiatry Research · 1989 · 34.7K citations
Medicine, Psychiatry, Psychology +16
Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent Insomnia
Charles M. Morin, Annie Vallières, Bernard Guay et al. · JAMA · 2009 · 786 citations · Full text
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Suzanne M. Bertisch, Shoshana J. Herzig, John W. Winkelman et al. · SLEEP · 2014 · 309 citations · Full text